Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
102
- −3 vs. Q1 2026
- Total value $219.22M
Superinvestors holding FHTX
0
- None of the superinvestors held FHTX at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by FHTX insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2024 | Sep 20 – Sep 23, 2024 | Costa CarlosChief People Officer | SSaleCommon Stock | −36.61K | $10.043 | −$367.71K | 0 | −100.0% | SEC10b5-1 |
| Sep 20, 2024 | Sep 18, 2024 | Costa CarlosChief People Officer | SSaleCommon Stock | −11.57K | $10.05 | −$116.32K | 0 | −100.0% | SEC10b5-1 |
| Sep 18, 2024 | Sep 16 – Sep 17, 2024 | Costa CarlosChief People Officer | SSaleCommon Stock | −10.67K | $10.0385 | −$107.13K | 0 | −100.0% | SEC10b5-1 |
| Sep 11, 2024 | Sep 9, 2024 | Bellon Steven F.Chief Scientific Officer | SSaleCommon Stock | −20K | $9.50 | −$190K | 101.96K | −16.4% | SEC10b5-1 |
| May 24, 20245:05 PM ET | May 22, 2024 | AFEYAN NOUBAR and 3 others10% Owner | PPurchaseCommon Stock · Derivative | +3.63M | $5.5099 | +$20M | 1.81M | – | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in FHTX at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 12,674,120 | $61.85M | 4.02% | 00.0% | Unchanged |
| BVF INC/IL | 5,842,000 | $28.51M | 0.73% | 00.0% | Unchanged |
| FMR LLC | 5,705,958 | $27.85M | 0.00% | −341,240−5.6% | Reduced |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,394,367 | $21.44M | 0.22% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,626,832 | $12.82M | 0.00% | +261,966+11.1% | Added |